Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a slow-growing, non-aggressive type of pancreatic cyst called an IPMN (intraductal papillary mucinous neoplasm) that is currently being monitored
- People who have been diagnosed with a more serious form of IPMN, or a type of pancreatic cancer (adenocarcinoma) connected to an IPMN, where the tumour can be surgically removed and has not yet been treated
- People aged 18 years or older, both male and female
- People who are able to sign a written consent form agreeing to take part in the study
Who may not be able to join:
- People who are unable to provide written consent to participate
- People whose past medical records cannot be traced for the part of the study that looks back at historical information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carmine Carbone, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: 0630155894
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Association of IPMNs tumorigenic progression with a molecular profile
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.